Annual EBITDA
$249.12M$33.38M-11.82%
Summary
- Current Value
- As of today, RDNT annual EBITDA is $249.12M, down -11.82% on
- Historical Performance
- RDNT annual EBITDA is down -6.27% over the past 3 years, and up +12.55% over the past 5 years
- All-Time High Comparison
- RDNT annual EBITDA is currently -11.82% below its historical high of $282.49M set on
- 3-Year Low Comparison
- RDNT annual EBITDA is +6.20% above its 3-year low of $234.56M reached on an earlier date
- Sector Comparison
- RDNT annual EBITDA is higher than 88.95% of companies in Healthcare sector
EBITDA Chart
Add series to chart1/6
Series
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual EBITDA | $249.12M | -11.8% | -6.3% | +12.6% | +165.3% | |
| Quarterly EBITDA | $74.63M | +7.6% | +39.2% | +20.4% | +198.5% | |
| TTM EBITDA | $230.33M | -12.3% | +0.3% | +36.6% | +150.7% | |
| Price | $78.20 | +8.2% | +311.6% | +286.8% | +2524.2% | |
| PE Ratio | - | – | – | – | – | |
| Annual Revenue | $1.83B | +13.2% | +39.1% | +58.5% | +248.9% | |
| Annual EPS | $0.04 | -20.6% | -91.9% | -87.3% | +162.3% | |
| Annual EBIT | $111.28M | +19.6% | +17.0% | +50.6% | +177.4% | |
| Annual Net Income | $38.84M | +28.0% | -12.4% | +65.7% | +1885.6% |
EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $282.49M | -11.8% | |
| 5Y | $282.49M | -11.8% | |
| All | $282.49M | -11.8% |
EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $234.56M | N/A | +6.2% |
| 5Y | $173.85M | N/A | +43.3% |
| All | -$44.15M | +664.2% |
EBITDA History
FAQ
What is the current annual EBITDA of RDNT?
As of today, RDNT annual EBITDA is $249.12M
What is 1-year change in RDNT annual EBITDA?
RDNT annual EBITDA is down -11.82% year-over-year
What is 3-year change in RDNT annual EBITDA?
RDNT annual EBITDA is down -6.27% over the past 3 years
How far is RDNT annual EBITDA from its all-time high?
RDNT annual EBITDA is currently -11.82% below its historical high of $282.49M set on December 31, 2023
How does RDNT annual EBITDA rank versus sector peers?
RDNT annual EBITDA is higher than 88.95% of companies in Healthcare sector
When is RDNT next annual earnings release?
The next annual earnings release for RDNT is on
Quarterly EBITDA
$74.63M$3.18M+4.45%
Summary
- Current Value
- As of today, RDNT quarterly EBITDA is $74.63M, up +4.45% on
- Historical Performance
- RDNT quarterly EBITDA is up +7.62% year-over-year, and up +39.18% over the past 3 years
- All-Time High Comparison
- RDNT quarterly EBITDA is currently -5.51% below its historical high of $78.98M set on
- 3-Year Low Comparison
- RDNT quarterly EBITDA is +301.41% above its 3-year low of $18.59M reached on
- Sector Comparison
- RDNT quarterly EBITDA is higher than 87.24% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly EBITDA | $74.63M | +4.5% | +7.6% | +39.2% | +20.4% | |
| Annual EBITDA | $249.12M | – | -11.8% | -6.3% | +12.6% | |
| TTM EBITDA | $230.33M | +2.4% | -12.3% | +0.3% | +36.6% | |
| Price | $78.20 | +7.4% | +8.2% | +311.6% | +286.8% | |
| PE Ratio | - | – | – | – | – | |
| Quarterly Revenue | $522.87M | +5.0% | +13.4% | +49.4% | +79.2% | |
| Quarterly EPS | $0.07 | -63.4% | +63.9% | +503.4% | -40.9% | |
| Quarterly EBIT | $34.83M | -1.8% | +1.4% | +406.8% | +44.7% | |
| Quarterly Net Income | $13.89M | -39.7% | +13.3% | +115.4% | +35.8% |
Quarterly EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $74.63M | at high | |
| 3Y | $77.35M | -3.5% | |
| 5Y | $78.98M | -5.5% | |
| All | $78.98M | -5.5% |
Quarterly EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $18.59M | +301.4% | |
| 3Y | $18.59M | +301.4% | |
| 5Y | $18.59M | +301.4% | |
| All | -$1.66M | +4609.1% |
Quarterly EBITDA History
FAQ
What is the current quarterly EBITDA of RDNT?
As of today, RDNT quarterly EBITDA is $74.63M
What is RDNT quarterly EBITDA most recent change?
RDNT quarterly EBITDA was up +4.45% on September 30, 2025
What is 1-year change in RDNT quarterly EBITDA?
RDNT quarterly EBITDA is up +7.62% year-over-year
How far is RDNT quarterly EBITDA from its all-time high?
RDNT quarterly EBITDA is currently -5.51% below its historical high of $78.98M set on September 30, 2021
How does RDNT quarterly EBITDA rank versus sector peers?
RDNT quarterly EBITDA is higher than 87.24% of companies in Healthcare sector
When is RDNT next earnings release?
The next earnings release for RDNT is on
TTM EBITDA
$230.33M$5.28M+2.35%
Summary
- Current Value
- As of today, RDNT TTM EBITDA is $230.33M, up +2.35% on
- Historical Performance
- RDNT TTM EBITDA is down -12.35% year-over-year, and up +0.33% over the past 3 years
- All-Time High Comparison
- RDNT TTM EBITDA is currently -18.47% below its historical high of $282.49M set on
- 3-Year Low Comparison
- RDNT TTM EBITDA is +6.00% above its 3-year low of $217.29M reached on an earlier date
- Sector Comparison
- RDNT TTM EBITDA is higher than 86.97% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM EBITDA | $230.33M | +2.4% | -12.3% | +0.3% | +36.6% | |
| Annual EBITDA | $249.12M | – | -11.8% | -6.3% | +12.6% | |
| Quarterly EBITDA | $74.63M | +4.5% | +7.6% | +39.2% | +20.4% | |
| Price | $78.20 | +7.4% | +8.2% | +311.6% | +286.8% | |
| PE Ratio | - | – | – | – | – | |
| TTM Revenue | $1.97B | +3.2% | +11.1% | +42.8% | +85.0% | |
| TTM EPS | -$0.18 | +13.3% | -171.7% | -234.8% | +15.6% | |
| TTM EBIT | $83.04M | +0.6% | -27.6% | +68.5% | +418.8% | |
| TTM Net Income | $21.41M | +8.3% | -30.1% | -28.5% | +10000.0% |
TTM EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $251.09M | N/A | -8.3% |
| 3Y | $282.49M | -18.5% | |
| 5Y | $282.49M | -18.5% | |
| All | $282.49M | -18.5% |
TTM EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $223.59M | +3.0% | |
| 3Y | $217.29M | N/A | +6.0% |
| 5Y | $174.42M | N/A | +32.0% |
| All | $1.61M | >+9999.0% |
TTM EBITDA History
FAQ
What is the current TTM EBITDA of RDNT?
As of today, RDNT TTM EBITDA is $230.33M
What is RDNT TTM EBITDA most recent change?
RDNT TTM EBITDA was up +2.35% on September 30, 2025
What is 1-year change in RDNT TTM EBITDA?
RDNT TTM EBITDA is down -12.35% year-over-year
How far is RDNT TTM EBITDA from its all-time high?
RDNT TTM EBITDA is currently -18.47% below its historical high of $282.49M set on December 31, 2023
How does RDNT TTM EBITDA rank versus sector peers?
RDNT TTM EBITDA is higher than 86.97% of companies in Healthcare sector
When is RDNT next earnings release?
The next earnings release for RDNT is on
EBITDA Formula
EBITDA = + + +
Data Sources & References
- RDNT Official Website www.radnet.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/790526/000079052625000008/0000790526-25-000008-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/790526/000162828025009481/0001628280-25-009481-index.htm
- RDNT Profile on Yahoo Finance finance.yahoo.com/quote/RDNT
- RDNT Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/rdnt